TC

22/10/2014 17:04

CMS (00867) unit in talks for Tibet Pharmaceutical matters

    China Medical System (CMS) (00867) said it noticed that Shanghai-listed Tibet Rhodiola Pharmaceutical Holdings Co., Ltd. issued an announcement that certain shareholders of the Tibet Pharmaceutical, including Shenzhen Kangzhe Pharmaceutical, a wholly-owned subsidiary of CMS, are considering entering into discussions in relation to certain matters concerning Tibet Pharmaceutical.
  It further mentions that the outcome of such discussion is uncertain and may involve significant matters.
  Shenzhen Kangzhe Pharmaceutical, together with other members of the CMS Group, hold an aggregate of about 8.64% stake in Tibet Pharmaceutical. 

全新節目《說說心理話》原生家庭對成長有咩影響?改善溝通有計可施?► 即睇

人氣文章
財經新聞
評論
專題
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

觀落陰:什麼是觀落陰?人人都可參加地府自由行?遊地獄到底係點?

帶你探索全新主頁!輕鬆探索精選資訊!

全新etnet健康網購 賞維他命D3 (價值$108) 齊齊提升免疫力